Major trial tests promising new combo against advanced colon cancer
NCT ID NCT05945901
Summary
This large study is testing whether adding a new drug called HR070803 to standard chemotherapy works better for people with advanced colorectal cancer that has spread and cannot be removed by surgery. About 669 patients will receive either the new combination or the current standard treatment to see which one better controls the cancer and is safer. The goal is to see if this new approach helps patients live longer without their cancer getting worse.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sun Yat-Sen University Cancer Center
Guangzhou, Guangdog, 510060, China
Conditions
Explore the condition pages connected to this study.